IDEAS home Printed from https://ideas.repec.org/r/eee/respol/v17y1988i3p139-154.html
   My bibliography  Save this item

Bibliometric analysis of U.S. pharmaceutical industry research performance

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Lee, Mushin & Son, Byoungho & Om, Kiyong, 1996. "Evaluation of national R&D projects in Korea," Research Policy, Elsevier, vol. 25(5), pages 805-818, August.
  2. Li, Xin & Tang, Xuli & Cheng, Qikai, 2022. "Predicting the clinical citation count of biomedical papers using multilayer perceptron neural network," Journal of Informetrics, Elsevier, vol. 16(4).
  3. Geuna, Aldo & Nesta, Lionel J.J., 2006. "University patenting and its effects on academic research: The emerging European evidence," Research Policy, Elsevier, vol. 35(6), pages 790-807, July.
  4. Dongyu Zang & Chunli Liu, 2023. "Exploring the clinical translation intensity of papers published by the world’s top scientists in basic medicine," Scientometrics, Springer;Akadémiai Kiadó, vol. 128(4), pages 2371-2416, April.
  5. D'Este, Pablo, 2005. "How do firms' knowledge bases affect intra-industry heterogeneity?: An analysis of the Spanish pharmaceutical industry," Research Policy, Elsevier, vol. 34(1), pages 33-45, February.
  6. Sternitzke, Christian, 2010. "Knowledge sources, patent protection, and commercialization of pharmaceutical innovations," Research Policy, Elsevier, vol. 39(6), pages 810-821, July.
  7. Stefano Brusoni & Paola Criscuolo & Aldo Geuna, 2005. "The knowledge bases of the world's largest pharmaceutical groups: what do patent citations to non-patent literature reveal?," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 14(5), pages 395-415.
  8. Roberto Camerani & Daniele Rotolo & Nicola Grassano, 2018. "Do firms publish? A multi-sectoral analysis," JRC Working Papers on Corporate R&D and Innovation 2018-05, Joint Research Centre.
  9. Bastian Rake, 2017. "Determinants of pharmaceutical innovation: the role of technological opportunities revisited," Journal of Evolutionary Economics, Springer, vol. 27(4), pages 691-727, September.
  10. David L. Deeds & Dona Decarolis & Joseph E. Coombs, 1998. "Firm-Specific Resources and Wealth Creation in High-Technology Ventures: Evidence from Newly Public Biotechnology Firms," Entrepreneurship Theory and Practice, , vol. 22(3), pages 55-73, April.
  11. Anna Giunta & Filippo M. Pericoli & Eleonora Pierucci, 2016. "University–Industry collaboration in the biopharmaceuticals: the Italian case," The Journal of Technology Transfer, Springer, vol. 41(4), pages 818-840, August.
  12. Boyack, Kevin W. & Patek, Michael & Ungar, Lyle H. & Yoon, Patrick & Klavans, Richard, 2014. "Classification of individual articles from all of science by research level," Journal of Informetrics, Elsevier, vol. 8(1), pages 1-12.
  13. K. Debackere & M. Luwel & Reinhilde Veugelers, 1999. "Can technology lead to a competitive advantage? A case study of Flanders using european patent data," Scientometrics, Springer;Akadémiai Kiadó, vol. 44(3), pages 379-400, March.
  14. Sujit Bhattacharya, 2004. "Mapping inventive activity and technological change through patent analysis: A case study of India and China," Scientometrics, Springer;Akadémiai Kiadó, vol. 61(3), pages 361-381, November.
  15. Bastian Krieger & Maikel Pellens & Knut Blind & Sonia Gruber & Torben Schubert, 2021. "Are firms withdrawing from basic research? An analysis of firm-level publication behaviour in Germany," Scientometrics, Springer;Akadémiai Kiadó, vol. 126(12), pages 9677-9698, December.
  16. Brusoni, Stefano & Geuna, Aldo, 2003. "An international comparison of sectoral knowledge bases: persistence and integration in the pharmaceutical industry," Research Policy, Elsevier, vol. 32(10), pages 1897-1912, December.
  17. Pablo D'Este Cukierman, 2004. "Persistent Knowledge Specialisation and Intra-Industry Heterogeneity: an Analysis of the Spanish Pharmaceutical Industry," SPRU Working Paper Series 110, SPRU - Science Policy Research Unit, University of Sussex Business School.
  18. Anckaert, Paul-Emmanuel & Cassiman, David & Cassiman, Bruno, 2020. "Fostering practice-oriented and use-inspired science in biomedical research," Research Policy, Elsevier, vol. 49(2).
  19. Larsen, Maria Theresa, 2011. "The implications of academic enterprise for public science: An overview of the empirical evidence," Research Policy, Elsevier, vol. 40(1), pages 6-19, February.
  20. Cortés-Sánchez, Julián David, 2019. "Bibliometric outlook of the most cited documents in business, management and accounting in Ibero-America," SocArXiv cqa3z, Center for Open Science.
  21. Eleonora Pierucci, 2015. "University-industry linkages. Among italian regions: a supply-demand analysis," RIVISTA DI ECONOMIA E STATISTICA DEL TERRITORIO, FrancoAngeli Editore, vol. 2015(2), pages 5-33.
  22. Rotolo, Daniele & Camerani, Roberto & Grassano, Nicola & Martin, Ben R., 2022. "Why do firms publish? A systematic literature review and a conceptual framework," Research Policy, Elsevier, vol. 51(10).
  23. Gomez, I. & Fernandez, M. T. & Zulueta, M. A. & Cami, J., 1995. "Analysis of biomedical research in Spain," Research Policy, Elsevier, vol. 24(3), pages 459-471, May.
  24. Jun Peng Yuan & Wei Ping Yue & Cheng Su & Zheng Wu & Zheng Ma & Yun Tao Pan & Nan Ma & Zhi Yu Hu & Fei Shi & Zheng Lu Yu & Yi Shan Wu, 2010. "Patent activity on water pollution and treatment in China—a scientometric perspective," Scientometrics, Springer;Akadémiai Kiadó, vol. 83(3), pages 639-651, June.
  25. Xin Li & Xuli Tang & Wei Lu, 2023. "Tracking biomedical articles along the translational continuum: a measure based on biomedical knowledge representation," Scientometrics, Springer;Akadémiai Kiadó, vol. 128(2), pages 1295-1319, February.
  26. Rémi Barré & Françoise Laville, 1994. "La bibliométrie des brevets : une mesure de l'activité technologique," Économie et Statistique, Programme National Persée, vol. 275(1), pages 71-81.
  27. Cassiman, Bruno & Veugelers, Reinhilde & Zuniga, Pluvia, 2007. "Science linkages and innovation performance: An analysis on CIS-3 firms in Belgium," IESE Research Papers D/671, IESE Business School.
  28. Deeds, David L. & Decarolis, DONA & Coombs, Joseph, 2000. "Dynamic capabilities and new product development in high technology ventures: An empirical analysis of new biotechnology firms," Journal of Business Venturing, Elsevier, vol. 15(3), pages 211-229, May.
  29. Godin, Benoit, 1996. "Research and the practice of publication in industries," Research Policy, Elsevier, vol. 25(4), pages 587-606, June.
  30. Deeds, David L. & Decarolis, Dona & Coombs, Joseph E., 1997. "The impact of firmspecific capabilities on the amount of capital raised in an initial public offering: Evidence from the biotechnology industry," Journal of Business Venturing, Elsevier, vol. 12(1), pages 31-46, January.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.